Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3266
Selected: 0
NCT IDTitle
NCT00005969Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease
NCT07438626Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma
NCT00087685RAD001 in Recurrent Endometrial Cancer Patients
NCT04009590Quit4Health Intervention in Supporting Smoking Cessation and Preventing Smoking Initiation in Young Adults
NCT00410488Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
NCT03283917Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
NCT04592250Financial Toxicity in Cancer Patients
NCT02782403Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
NCT06435286Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
NCT02171078Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance
NCT00199849NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
NCT04310397Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
NCT03085927Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents
NCT00903760Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
NCT00507182Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
NCT07318324Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
NCT03128879Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
NCT02592356Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
NCT01295931Nuclear and Near-Infrared (NIR) Imaging in Melanoma
NCT04185337Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes
NCT06157801Evaluation of Hereditary Cancer Educational Videos
NCT00038142Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
NCT00946270Pomalidomide for Myelofibrosis Patients
NCT01504789Part II: Exercise in Hispanic Breast Cancer Survivors
NCT01815346Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
NCT00590902Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer
NCT05059470IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC
NCT011391514'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies
NCT01628029Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer
NCT01900002Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00094445Trial of Curcumin in Advanced Pancreatic Cancer
NCT01854554Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)
NCT00682994Patient and Family Decision Making in the Palliative Care Setting
NCT02812056Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
NCT06532877Telephone Support in Advanced Gastrointestinal Cancer
NCT01092741Late Chronic Phase Chronic Myelogenous Leukemia
NCT00506857Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
NCT01012401Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer
NCT01649622Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)
NCT06698822A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
NCT0641490218F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
NCT02272686Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma
NCT04592237Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer
NCT06909201Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
NCT01371630Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
NCT02502786Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
NCT02420795Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT05985954Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
NCT02459002Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project
NCT06083896Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome